🧬 SinoBioData Academic Portal
Open AccessDOI: 10.12307/2026.21314Original Research

Shaoyang Shenggu Fang inhibits oxidative stress and delays cartilage aging in rats with knee osteoarthritis

Yong Qiao¹,Xin Sun¹,Guoyou Wang¹,Lei Zhang¹,Huarui Shen¹,Huan Liu¹,Taiyuan Guan¹✉

• Southwest Medical University Affiliated Hospital of Traditional Chinese Medicine, Luzhou 646000, Sichuan Province, China

Read Executive PreviewQuick FAQ
Shaoyang Shenggu Fang inhibits oxidative stress and delays cartilage aging in rats with knee osteoarthritis
Graphical Abstract / Figure
Published In
Chinese Journal of Tissue Engineering Research
Published:January 15, 2026Edition:Vol 1900, Issue 28 • pp. 100-112Citation:Yong Qiao et al. (2026), Chinese Journal of Tissue Engineering Research
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Chinese Journal of Tissue Engineering Research (中国组织工程研究).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • •• Shaoyang Shenggu Fang significantly reduces cartilage degeneration and Mankin scores in a rat model of knee osteoarthritis. • The formula decreases serum levels of pro-inflammatory cytokines (IL-1β, TNF-Îą, IL-6) and modulates oxidative stress markers (increases SOD and GSH-Px, decreases MDA). • Shaoyang Shenggu Fang downregulates senescence markers p21Cip1 and p16INK4a, and inhibits Wnt/β-catenin pathway activation. • The therapeutic mechanism involves inhibition of oxidative stress via regulation of the Wnt/β-catenin pathway, thereby delaying cartilage senescence.
Sponsored Research Highlight

Abstract

BACKGROUND: Preliminary studies have demonstrated that Shaoyang Shenggu Fang can alleviate joint cartilage degeneration and promote cartilage repair, but its specific mechanism for alleviating knee osteoarthritis symptoms remains unclear. The Wnt/β-catenin pathway and oxidative stress play crucial roles in maintaining articular cartilage homeostasis. OBJECTIVE: To investigate the molecular mechanisms by which Shaoyang Shenggu Fang regulates the Wnt/β-catenin pathway to inhibit oxidative stress in cartilage and thereby delay cartilage aging in a rat model of knee osteoarthritis. METHODS: Thirty-two Sprague-Dawley rats were randomly divided into four groups: a blank control group, a model group, a Western medicine group, and a Chinese medicine group. Animal models of knee osteoarthritis were established in all groups except for the blank control group by transecting the anterior cruciate ligament and resecting the anterior horn of the medial meniscus. After 28 days of modeling, the Chinese medicine group was administered concentrated Shaoyang Shenggu Fang at a dose of 16 g/(kg¡d) by gavage, the Western medicine group received glucosamine hydrochloride solution at 4 mL/d, and the blank and model groups received the same volume of normal saline. After 4 weeks, hematoxylin-eosin staining and Safranin O-fast green staining were used to observe the degree of cartilage damage and degeneration. ELISA was used to detect serum levels of inflammatory factors and oxidative stress indicators. Western blot was used to detect the expression of p21Cip1, p16INK4a, and Wnt signaling pathway-related proteins in knee cartilage. RESULTS AND CONCLUSION: Compared with the model group, the Western medicine and Chinese medicine groups showed significant improvement in cartilage defects, thinning of the cartilage layer, and decreased density, with significantly lower Mankin scores (P < 0.05). Compared with the model group, serum levels of interleukin-1β, tumor necrosis factor-ι, and interleukin-6 were significantly decreased in the Western medicine and Chinese medicine groups (P < 0.05), while superoxide dismutase and glutathione peroxidase levels were increased and malondialdehyde concentration was decreased (all P < 0.05). In the Chinese medicine group, the expression levels of p21Cip1, p16INK4a, and Wnt5a proteins were significantly decreased (P < 0.05 and P < 0.01), β-catenin and C-Myc protein expression levels were decreased (P < 0.05), and glycogen synthase kinase-3β protein expression was significantly increased (P < 0.05). These results suggest that Shaoyang Shenggu Fang can significantly reduce inflammation and alleviate cartilage aging in rats with knee osteoarthritis, and the potential mechanism may be through regulation of the Wnt/β-catenin pathway to inhibit cartilage oxidative stress.

1. Introduction

Knee osteoarthritis (KOA) is a common age-related degenerative disease characterized by joint inflammation and chondrocyte senescence, with the main pathological hallmark being articular cartilage degeneration [1-2]. Its complex pathological process often originates from biochemical factors and cellular physiological changes in the synovial tissue, leading to histological and cytological alterations—structural defects in hyaline articular cartilage, loss of subchondral bone integrity, tissue hypertrophy, increased bone mass, and structural changes in the joint, ultimately resulting in whole-tissue dysfunction [3]. Knee joint tissues age over time, and the number of senescent chondrocytes is closely related to age; moreover, due to the important role of bone-cartilage coupling, the senescence tendency of bone cells also increases during aging [4].

The Wnt/β-catenin pathway plays a crucial role in maintaining articular cartilage homeostasis. When the joint is injured, the quiescent Wnt/β-catenin pathway rapidly responds and activates, with Wnt being highly expressed in osteoarthritis and promoting abnormal accumulation of β-catenin [5]. Chondrocyte senescence is a key mechanism in the pathogenesis of osteoarthritis. Studies have shown that the Wnt/β-catenin pathway can promote the senescent phenotype of chondrocytes by downregulating silent information regulator 1 and p53 acetylation [6]. Additionally, the progression of osteoarthritis is closely related to reactive oxygen species (ROS) and oxidative stress. ROS are produced by NADPH oxidases and mitochondria in chondrocytes, affecting gene expression, apoptosis, extracellular matrix synthesis, and inflammatory cytokine production. Overexpression of NADPH oxidase exacerbates oxidative stress and accelerates osteoarthritis progression [7]. The Wnt/β-catenin signaling pathway and oxidative stress interact, making the regulation of the Wnt/β-catenin signaling pathway a potential therapeutic target for KOA.

According to the classic text Lingshu·Genjie, “Shaoyang is the pivot; if the pivot is broken, the bones will be weak and unstable, so for those with flaccidity, treat Shaoyang.” The Shaoyang qi flows along the meridians to nourish the bones, promoting bone growth and joint strength, which is the concept of “Shaoyang governing bone.” While “kidney governs bone” emphasizes the “body” of bone, “Shaoyang governs bone” emphasizes its “function” [8]. The core of the “Shaoyang Sheng Gu” theory is that the Shaoyang meridian plays a dominant role in bone formation and metabolic balance. Clinically, regulating Shaoyang has been used to treat bone diseases, and the Shaoyang Shenggu Fang, derived from the classic formula Xiaochaihu Tang and the theory of “Shaoyang governing bone,” combined with the clinical experience of national renowned TCM expert Sun Tongjiao, has shown efficacy in treating KOA.

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
Yong Qiao, Xin Sun, Guoyou Wang, Lei Zhang, Huarui Shen, Huan Liu, Taiyuan Guan (2026). Shaoyang Shenggu Fang inhibits oxidative stress and delays cartilage aging in rats with knee osteoarthritis. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21314
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

What is Shaoyang Shenggu Fang?

Shaoyang Shenggu Fang is a traditional Chinese medicine formula derived from the classic Xiaochaihu Tang, incorporating the theory of 'Shaoyang governing bone' from the Huangdi Neijing and the clinical experience of Professor Sun Tongjiao. It consists of eight herbs: Chaihu (Bupleurum), Banxia (Pinellia), Dangshen (Codonopsis), Huangqin (Scutellaria), Dazao (Jujube), Gancao (Licorice), Gusuibu (Drynaria), and Chuanniuxi (Cyathula). It is used to treat knee osteoarthritis by harmonizing Shaoyang, unblocking the pivot, nourishing the liver and kidney, and promoting blood circulation to relieve pain.

How does Shaoyang Shenggu Fang work in treating knee osteoarthritis?

The study suggests that Shaoyang Shenggu Fang alleviates knee osteoarthritis by inhibiting oxidative stress and delaying cartilage senescence. It downregulates the Wnt/β-catenin signaling pathway, reduces inflammatory cytokines (IL-1β, TNF-ι, IL-6), and modulates oxidative stress markers (increasing SOD and GSH-Px, decreasing MDA). This leads to reduced cartilage degeneration and improved joint health.

What is the role of the Wnt/β-catenin pathway in knee osteoarthritis?

The Wnt/β-catenin pathway is crucial in maintaining cartilage homeostasis. In osteoarthritis, it becomes overactivated, leading to abnormal β-catenin accumulation, which promotes chondrocyte senescence and cartilage degradation. It also interacts with oxidative stress, contributing to the progression of the disease. Inhibiting this pathway is a potential therapeutic strategy.

What were the key findings of the study on Shaoyang Shenggu Fang?

The study found that Shaoyang Shenggu Fang significantly improved cartilage damage in rats with knee osteoarthritis, reduced Mankin scores, decreased serum inflammatory cytokines, and modulated oxidative stress markers. It also downregulated senescence markers (p21Cip1, p16INK4a) and Wnt pathway proteins (Wnt5a, β-catenin, C-Myc), while increasing GSK-3β expression. These effects suggest that the formula delays cartilage aging by inhibiting oxidative stress via the Wnt/β-catenin pathway.

What is the significance of this research for clinical practice?

This research provides scientific evidence for the use of Shaoyang Shenggu Fang in treating knee osteoarthritis. It elucidates the molecular mechanism, showing that the formula can modulate the Wnt/β-catenin pathway and oxidative stress, which are key factors in cartilage degeneration. This supports the potential of Shaoyang Shenggu Fang as an effective therapeutic option for KOA, and may guide future clinical applications and drug development.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF